Stay updated on EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial
Sign up to get notified when there's something new on the EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial page.

Latest updates to the EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial page
- CheckyesterdayChange DetectedThe page now presents the ClinicalTrials.gov record for the EG-1962 versus enteral nimodipine study, including its design, participant criteria, study locations, and outcome measures. It also shows that the trial was terminated after a review found a low probability of meeting its primary endpoint.SummaryDifference76%

- Check8 days agoChange DetectedThe site revision shown in the footer changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedA site-wide banner announces an NIH terminology transition, saying federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.” The clinical trial page itself remains a 403 error page.SummaryDifference1%

- Check22 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now renders a 403 Forbidden error with minimal navigation (header/footer and a Home link), indicating access to the study record cannot be loaded.SummaryDifference0.5%

Stay in the know with updates to EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EG-1962 vs Oral Nimodipine in Subarachnoid Hemorrhage Clinical Trial page.